The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bikbavova G.R.

Omsk State Medical University

Livzan M.A.

Omsk State Medical University

Lisyutenko N.S.

Omsk State Medical University

Romanyuk A.E.

Omsk State Medical University

Zaporenko M.Yu.

Regional Clinical Hospital

Panova T.Yu.

Regional Clinical Hospital

Insulin resistance as a cardiovascular risk factor in patients with ulcerative colitis

Authors:

Bikbavova G.R., Livzan M.A., Lisyutenko N.S., Romanyuk A.E., Zaporenko M.Yu., Panova T.Yu.

More about the authors

Read: 1477 times


To cite this article:

Bikbavova GR, Livzan MA, Lisyutenko NS, Romanyuk AE, Zaporenko MYu, Panova TYu. Insulin resistance as a cardiovascular risk factor in patients with ulcerative colitis. Russian Journal of Evidence-Based Gastroenterology. 2024;13(3):42‑49. (In Russ.)
https://doi.org/10.17116/dokgastro20241303142

Recommended articles:
Differential diagnosis of anemia in ulce­rative coli­tis: a clinical case. Russian Journal of Evidence-Based Gastroenterology. 2025;(2):115-120
Modern aspe­cts of gestational diabetes mellitus: defi­nition, risk factors. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):35-41
Prospects for treating Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):54-60
Drinking mine­ral water for progressive resi­stance to insu­lin. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(2):24-30

References:

  1. Shelygin YA, Ivashkin VT, Belousova EA, Reshetov IV, Maev IV, Achkasov SI, Abdulganieva DI, Alekseeva OA, Bakulin IG, Barysheva OY, Bolikhov KV, Vardanyan AV, Veselov AV, Veselov VV, Golovenko OV, Gubonina IV, Denisenko VL, Dolgushina AI, Kashnikov VN, Knyazev OV, Kostenko NV, Lakhin AV, Makarchuk PA, Moskalev AI, Nanaeva BA, Nikitin IG, Nikitina NV, Odintsova AK, Omelyanovskiy VV, Oshchepkov AV, Pavlenko VV, Poluektova EA, Sitkin SI, Sushkov OI, Tarasova LV, Tkachev AV, Timerbulatov VM, Uspenskaya YB, Frolov SA, Khlynova OV, Chashkova EY, Chesnokova OV, Shapina MV, Sheptulin AA, Shifrin OS, Shkurko TV, Shchukina OB. Ulcerative colitis (K51), adults. Koloproktologia. 2023;22(1):10-44. (In Russ.). https://doi.org/10.33878/2073-7556-2023-22-1-10-44
  2. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. Gastroenterology and Hepatology. 2020;5(1):17-30.  https://doi.org/10.1016/S2468-1253(19)30333-4
  3. Bikbavova GR, Livzan MA, Sovalkin VI, Turchaninov DV, Lopatina OE, Tret’yakova TV, Akhramovich AP, Gordienko TS. Modern lifestyle and its impact on the ulcerative colitis incidence. Arkhiv vnutrennei meditsiny. 2019;9(3):188-194. (In Russ.). https://doi.org/10.20514/2226-6704-2019-9-3-188-193
  4. Turner D, Ricciuto A, Lewis A, D’Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Schölmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel J-F, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570-1583. https://doi.org/10.1053/j.gastro.2020.12.031
  5. Argollo M, Gilardi D, Peyrin-Biroulet C, Chabot J-F, Peyrin-Biroulet L, Danese S. Comorbidities in inflammatory bowel disease: a call for action. Lancet. Gastroenterology and Hepatology. 2019;4(8):643-654.  https://doi.org/10.1016/S2468-1253(19)30173-6
  6. Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nature Reviews. Gastroenterology and Hepatology. 2021;18(1):56-66.  https://doi.org/10.1038/s41575-020-00360-x
  7. He J, Zhang S, Qiu Y, Liu F, Liu Z, Tan J, Hu F, Wu X, Wang Y, Zhou L, Hu S, Chen M, Liao X, Zhuang X, Mao R. Ulcerative colitis increases risk of hypertension in a UK biobank cohort study. United European Gastroenterology. 2023;11(1):19-30.  https://doi.org/10.1002/ueg2.12351
  8. Massironi S, Mulinacci G, Gallo C, Viganò C, Fichera M, Villatore A, Peretto G, Danese S. The oft-overlooked cardiovascular complications of inflammatory bowel disease. Expert Review of Clinical Immunology. 2023;19(4):375-391.  https://doi.org/10.1080/1744666X.2023.2174971
  9. D’Ascenzo F, Bruno F, Iannaccone M, Testa G, De Filippo O, Giannino G, Caviglia GP, Bernstein CN, De Ferrari GM, Bugianesi E, Armandi A, Ribaldone DG. Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis. International Journal of Cardiology. 2023;378:96-104.  https://doi.org/10.1016/j.ijcard.2023.02.042
  10. Gordon H, Burisch J, Ellul P, Karmiris K, Katsanos K, Allocca M, Bamias G, Barreiro-de Acosta M, Braithwaite T, Greuter T, Harwood C, Juillerat P, Lobaton T, Müller-Ladner U, Noor N, Pellino G, Savarino E, Schramm C, Soriano A, Stein JM, Uzzan M, van Rheenen PF, Vavricka SR, Vecchi M, Zuily S, Kucharzik T. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease. Journal of Crohn’s and Colitis. 2024;18(1):1-37.  https://doi.org/10.1093/ecco-jcc/jjad108
  11. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Rossiiskii kardiologicheskii zhurnal. 2022;27(7):5155. (In Russ.). https://doi.org/10.15829/1560-4071-2022-5155
  12. Burisch J. Is hypertension an extra-intestinal manifestation of inflammatory bowel disease? United European Gastroenterology. 2023; 11(1):7-8.  https://doi.org/10.1002/ueg2.12359
  13. Rungoe C, Andersen NN, Jess T. Inflammatory bowel disease and risk of coronary heart disease. Trends in Cardiovascular Medicine. 2015;25(8):699-704.  https://doi.org/10.1016/j.tcm.2015.03.010
  14. Jucan AE, Gavrilescu O, Dranga M, Popa IV, Mihai BM, Prelipcean CC, Mihai C. Ischemic Heart Disease in Patients with Inflammatory Bowel Disease: Risk Factors, Mechanisms and Prevention. Life. 2022;12(8):1113. https://doi.org/10.3390/life12081113
  15. Jin M, Qian Z, Yin J, Xu W, Zhou X. The role of intestinal microbiota in cardiovascular disease. Journal of Cellular and Molecular Medicine. 2019;23(4):2343-2350. https://doi.org/10.1111/jcmm.14195
  16. Bikbavova GR, Livzan MA, Lisyutenko NS, Martynenko OV, Indutny AV. Prevalence of overweight and obesity in patients with ulcerative colitis: a case-control study. Eksperimental’naya i klinicheskaya gastroenterologiya. 2023;(4):6-11. (In Russ.). https://doi.org/10.31146/1682-8658-ecg-212-4-6-11
  17. Uspenskiy YP, Ivanov SV, Mayorova OV, Fominykh JA. Inflammatory bowel disease and obesity: current state of issue. Meditsinskii alfavit. 2020;(37):29-34. (In Russ.). https://doi.org/10.33667/2078-5631-2020-37-29-34
  18. Iazvennyi kolit. Klinicheskie rekomendatsii. 2022. Odobreno Nauchno-prakticheskim Sovetom Minzdrava Rossii. Accessed January 30, 2024. (In Russ.). https://cr.minzdrav.gov.ru/schema/193_1#doc_b
  19. Arterial’naya gipertenziya u vzroslykh. Klinicheskie rekomendatsii. 2020. Odobreno Nauchno-prakticheskim Sovetom Minzdrava Rossii. Accessed May 19, 2024. (In Russ.). https://scardio.ru/content/Guidelines/Clinic_rek_AG_2020.pdf
  20. Stabil’naya ishemicheskaya bolezn’ serdtsa. Klinicheskie rekomendatsii. Odobreno Nauchno-prakticheskim Sovetom Minzdrava Rossii. 2020. Accessed May 19, 2024. (In Russ.). https://scardio.ru/content/Guidelines/2020/Clinic_rekom_IBS-unlocked.pdf
  21. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31.  https://doi.org/10.1093/ageing/afy169
  22. Bicbavova GR, Drapkina OM, Livzan MA, Lisyutenko NS, Romanyuk AE. Cardiovascular risk factors in patients with ulcerative colitis. Terapevticheskii arkhiv. 2023;95(8):658-663. (In Russ.). https://doi.org/10.26442/00403660.2023.08.202338
  23. Korneeva ON, Drapkina OM. Pathogenetic interaction of arterial hypertension and insulin resistance. Rossiiskii kardiologicheskii zhurnal. 2006;(5):100-103. (In Russ.).
  24. Doğan AN, Kahraman R, Akar T. Evaluation of insulin resistance and beta cell activity in patients with inflammatory bowel disease. European Review for Medical and Pharmacological Sciences. 2022;26(11):39-89-3994. https://doi.org/10.26355/eurrev_202206_28969
  25. Garvey WT, Garber AJ, Mechanick JI, Bray GA, Dagogo-Jack S, Einhorn D, Grunberger G, Handelsman Y, Hennekens CH, Hurley DL, McGill J, Palumbo P, Umpierrez G. On behalf of the AACE obesity scientific C. American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocrine Practice. 2014;20(9):977-989.  https://doi.org/10.4158/EP14280.PS

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.